UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 168

Sortiert nach

MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer

Nature communications, 2021-08, Vol.12 (1), p.5066-5066, Article 5066

2021

Volltextzugriff (PDF)

Chiral magnetic conductivity in an interacting lattice model of parity-breaking Weyl semimetal

Physical review. B, Condensed matter and materials physics, 2015-11, Vol.92 (20), Article 205122

2015

Volltextzugriff (PDF)

EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205

British journal of cancer, 2014-08, Vol.111 (5), p.955-964

2014

Volltextzugriff (PDF)

PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer

Oncogene, 2016-05, Vol.35 (18), p.2322-2332

2016

Volltextzugriff (PDF)

The Use of Transitional Care Models in Patients With Stroke

The Journal of neuroscience nursing, 2015-08, Vol.47 (4), p.223

2015

Volltextzugriff (PDF)

Inhibition of cholesterol and steroid synthesis through miR-205 target gene SQLE is an intriguing treatment strategy in various in vitro and in vivo models of prostate cancer

European urology open science (Online), 2020-07, Vol.19, p.e1840

2020

Volltextzugriff (PDF)

Amiodarone, an anti-arrhythmic drug, is a new repurposed drug for bladder cancer therapy

European urology, 2024-03, Vol.85, p.S1905

2024

Volltextzugriff (PDF)

A0868 - Amiodarone, an anti-arrhythmic drug, is a new repurposed drug for bladder cancer therapy

European urology, 2024-03, Vol.85, p.S1905-S1905

2024

Volltextzugriff (PDF)

What if…? – Changes in the androgen receptor protein level are the main regulator of the androgen receptor’s activity

European urology open science (Online), 2022-10, Vol.44, p.S201

2022

Volltextzugriff (PDF)

A0371 - Alterations of the collagen pathway is linked to clinical outcome in prostate cancer

European urology, 2023-02, Vol.83, p.S538-S539

2023

Volltextzugriff (PDF)

Alterations of the collagen pathway is linked to clinical outcome in prostate cancer

European urology, 2023-02, Vol.83, p.S538-S539

2023

Volltextzugriff (PDF)

Not All Talk : Josh and Benny Safdie's Uncut Gems (2019)

Film international (Göteborg, Sweden), 2022-03, Vol.20 (1-2), p.177-180

Puhr, Thomas M.

2022

Volltextzugriff (PDF)

Knockdown of PIAS1 increases the sensitivity to radiotherapy in breast cancer

European journal of cancer (1990), 2018-04, Vol.92, p.S129

2018

Volltextzugriff (PDF)

443 (PB-076) - Knockdown of PIAS1 increases the sensitivity to radiotherapy in breast cancer

European journal of cancer (1990), 2018-04, Vol.92, p.S129-S129

2018

Volltextzugriff (PDF)

UP23 - The impact of glucocorticoid and chemotherapy treatment on cancer-associated fibroblast gene expression has consequences for extracellular matrix remodeling and epithelial compartment interaction

European urology open science (Online), 2023-10, Vol.56, p.S44-S44

2023

Volltextzugriff (PDF)

The impact of glucocorticoid and chemotherapy treatment on cancer-associated fibroblast gene expression has consequences for extracellular matrix remodeling and epithelial compartment interaction

European urology open science (Online), 2023-10, Vol.56, p.S44

2023

Volltextzugriff (PDF)

Biochemical inhibition of the MYC down-stream target RIOK1 induces apoptosis in prostate cancer cells

European urology open science (Online), 2022-10, Vol.44, p.S196

2022

Volltextzugriff (PDF)

Out-FOXOing therapy-resistant cancer cells

European urology open science (Online), 2022-10, Vol.44, p.S220

2022

Volltextzugriff (PDF)

Telaglenastat as a potential therapy in docetaxel resistant prostate cancer with a mesenchymal phenotype

European urology open science (Online), 2022-10, Vol.44, p.S160

2022

Volltextzugriff (PDF)

Impact of glucocorticoid treatment and elevated stromal GR signaling on extracellular matrix remodeling and epithelial compartment interaction with consequences for prostate cancer progression

European urology open science (Online), 2022-10, Vol.44, p.S214

2022

Volltextzugriff (PDF)

UP17 - Overcoming docetaxel resistance in advanced prostate cancer: Analysis of statin therapy from a cell-based model to a patient derived prostate cancer tissue micro array

European urology open science (Online), 2023-10, Vol.56, p.S36-S36

2023

Volltextzugriff (PDF)

Overcoming docetaxel resistance in advanced prostate cancer: Analysis of statin therapy from a cell-based model to a patient derived prostate cancer tissue micro array

European urology open science (Online), 2023-10, Vol.56, p.S36

2023

Volltextzugriff (PDF)

Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases

The American journal of pathology, 2009-05, Vol.174 (5), p.1921-1930

2009

Volltextzugriff (PDF)

Inhibition of the cholesterol metabolism via sterol regulatory element of binding protein (SREB-F1) overcomes docetaxel resistance in advanced prostate cancer

European urology open science (Online), 2022-10, Vol.44, p.S222

2022

Volltextzugriff (PDF)

Role of mitochondrial dynamics in tumorigenic potential and docetaxel resistance in prostate cancer

European urology open science (Online), 2022-10, Vol.44, p.S184

2022

Volltextzugriff (PDF)

1 – 25 von 168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(137)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer

Chiral magnetic conductivity in an interacting lattice model of parity-breaking Weyl semimetal

EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205

PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer

The Use of Transitional Care Models in Patients With Stroke

Inhibition of cholesterol and steroid synthesis through miR-205 target gene SQLE is an intriguing treatment strategy in various in vitro and in vivo models of prostate cancer

Amiodarone, an anti-arrhythmic drug, is a new repurposed drug for bladder cancer therapy

A0868 - Amiodarone, an anti-arrhythmic drug, is a new repurposed drug for bladder cancer therapy

What if…? – Changes in the androgen receptor protein level are the main regulator of the androgen receptor’s activity

A0371 - Alterations of the collagen pathway is linked to clinical outcome in prostate cancer

Alterations of the collagen pathway is linked to clinical outcome in prostate cancer

Not All Talk : Josh and Benny Safdie's Uncut Gems (2019)

Knockdown of PIAS1 increases the sensitivity to radiotherapy in breast cancer

443 (PB-076) - Knockdown of PIAS1 increases the sensitivity to radiotherapy in breast cancer

UP23 - The impact of glucocorticoid and chemotherapy treatment on cancer-associated fibroblast gene expression has consequences for extracellular matrix remodeling and epithelial compartment interaction

The impact of glucocorticoid and chemotherapy treatment on cancer-associated fibroblast gene expression has consequences for extracellular matrix remodeling and epithelial compartment interaction

Biochemical inhibition of the MYC down-stream target RIOK1 induces apoptosis in prostate cancer cells

Out-FOXOing therapy-resistant cancer cells

Telaglenastat as a potential therapy in docetaxel resistant prostate cancer with a mesenchymal phenotype

Impact of glucocorticoid treatment and elevated stromal GR signaling on extracellular matrix remodeling and epithelial compartment interaction with consequences for prostate cancer progression

UP17 - Overcoming docetaxel resistance in advanced prostate cancer: Analysis of statin therapy from a cell-based model to a patient derived prostate cancer tissue micro array

Overcoming docetaxel resistance in advanced prostate cancer: Analysis of statin therapy from a cell-based model to a patient derived prostate cancer tissue micro array

Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases

Inhibition of the cholesterol metabolism via sterol regulatory element of binding protein (SREB-F1) overcomes docetaxel resistance in advanced prostate cancer

Role of mitochondrial dynamics in tumorigenic potential and docetaxel resistance in prostate cancer

Suchergebnisse filtern